期刊文献+

性激素水平及ER、PR表达与乳腺纤维腺瘤的关系 被引量:3

Relationship between sex hormone levels, ER, PR expression and breast fibroadenoma
原文传递
导出
摘要 目的研究性激素水平及雌激素受体(ER)、孕激素受体(PR)表达在乳腺纤维腺瘤中的变化及意义。方法将研究对象分为纤维腺瘤组和正常组。采用化学发光法测定各组黄体期血清雌激素(E2)、孕酮(P)、泌乳素(PRL)水平,同时应用免疫组化法检测纤维腺瘤组中ER、PR的表达。结果纤维腺瘤组E2水平明显高于正常组,差异有统计学意义(P〈0.05),两组P、PRL水平比较差异无统计学意义(P〉0.05)。纤维腺瘤组中ER的阳性率为94.7%,PR的阳性率为69.3%,ER阳性强度差异有统计学意义(P〈0.05)。结论E2升高及ER高表达是乳腺纤维腺瘤发生的主要原因,与乳腺增生病原因相似。据此,临床上可采取措施对其进行积极治疗。 Objective To study the changes of sex hormone level, estrogen receptor (ER) and progesterone receptor (PR) expression levels and their significance in fibroadenoma of,breast. Methods The study objects were divided into fibroadenoma group and normal group. Chemiluminescence method was used to detect the luteal phase serum estrogen (E2), progesterone (P), prolactin (PRL) levels, and immunohistochemistry was used to detect ER, PR levels in fibroadenoma group. Results The level of E2 in fibroadenoma group was significantly higher than that in normal group, there was significant differ- ence between the two groups (P 〈 0.05 ). There were no significant differences in P and PRL levels be- tween the two groups (P 〉 0.05 ). The positive rate ER in fibroadenoma group was 94.7%, the positive rate of PR was 69.3%, and the differences were statistically significant for ER positive intensity between the two groups (P 〈 0.05 ). Conclusions The elevated levels of E2 and high expression levels of ER are the main reasons of breast fibroadenoma, which are similar to the causes of hyperplasia of mammry gland. So, active treatment should be given in clinics.
机构地区 开封市妇产医院
出处 《中国实用医刊》 2014年第7期63-64,共2页 Chinese Journal of Practical Medicine
关键词 乳腺纤维腺瘤 性激素 雌激素受体 孕激素受体 Fibroadenoma of breast Sex hormone Estrogen receptor Progesterone receptor
  • 相关文献

参考文献6

二级参考文献28

共引文献13

同被引文献24

  • 1纪福,张嘉栋.乳腺增生病中医辨证分型与性激素量变的关系[J].中国中西医结合外科杂志,2007,13(1):8-10. 被引量:14
  • 2Olu-Eddo AN,Ugiagbe EE.Benign breast lesions in an African population: A 25-year histopathologic'al review of 1864 cases[J].Niger Med J,2011,52(4):211-216.
  • 3Pilnik S.Clinieal diagnosis of benign breast diseases[J].J Reprod Med, 1979.22(6):277-290.
  • 4Tanos T, Rojo L,Echeverria P,et al.ER and PR signaling nodes during mamman' gland development[J].Breast Cancer Res,2012,14(4):210.
  • 5Watson CJ,Oliver CH.Khaled WT.Cytokine signalling in mammary gland development[J].J Reprod Immunol.2011,88(2): 124-129.
  • 6Simomoto MM,Naz 6 rio AC,Gebrim LH,et al.Morphometric Analysis of the Epithelium of MammaD' Fihroadenomas During the Proliferative and Seeretory Phases of the Menstrual Cycle[J].Breast J.1999.5(4):256-261.
  • 7Tanos T, Rojo LJ, Echeverria P, et al. ER and PR signaling nodes dur-ing mammary stand development [ J]. Breast Cancer Res, 2012, 14 (4) :210.
  • 8Watson CJ,Olivera CH, Khaled WT, Cytokine signalling in mammary gland development [ J]. J Reprod hnmunol, 2011, 88 ( 2 ) : 124 - 129.
  • 9Borthwick LA, Gardner A, De Soyza A, et ah Transforming growth Factor-β1 (TGF-β) driven epithelial to mesenchymal transition (EMT) is accentuated by tumour necrosis factor α (TNFα) via crosstatk between the SMAD and NF-kappar pathways [J].Cancer" Microenviron ,2012,5 ( 1 ) :45 - 57.
  • 10De Mattos CB, Binitie O, Dormans JP. Pathological fraetures in chil- dren[J]. Bone Joint Res,2012,1(10) :272 -280.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部